A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. ProQR Therapeutics N.V’s current trading price is -20.78% away from its 52-week high, while its distance from the 52-week low is 223.89%. The stock’s
ProQR Therapeutics N.V experienced a rather steady stock market performance. The highest value in the past year was recorded at $4.62 on 10/17/24 and the lowest value was $1.11 on 10/27/23. 52-week price history of PRQR Stock Studying a stock’s 52-week price history, which includes
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. ProQR Therapeutics N.V’s current trading price is -4.85% away from its 52-week high, while its distance from the 52-week low is 182.03%. The stock’s price
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. ProQR Therapeutics N.V’s current trading price is -42.86% away from its 52-week high, while its distance from the 52-week low is 69.37%. The stock’s price
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. ProQR Therapeutics N.V’s current trading price is -45.29% away from its 52-week high, while its distance from the 52-week low is 62.16%.
After the company announced an expansion of cooperation, shares of ProQR Therapeutics N.V. (Nasdaq: PRQR) were up 35.15% at $2.23 at the time of our last check in pre-market trading. What partnership will PRQR be extending? Eli Lilly and Company (NYSE: LLY) and ProQR Therapeutics
All rights reserved © 2024, Powered By Smart TechOne
